J.Y. Zhang¹ , D.W. Zhang^1,2

1 Department of Breast Surgery, the Second Affiliated of Harbin Medical University, Harbin, Heilongjiang, China
2 Heilongjiang Academy of Medical Sciences, Harbin, Heilongjiang, 150081, China
Author    Correspondence author
Cancer Genetics and Epigenetics, 2019, Vol. 7, No. 3   doi: 10.5376/cge.2018.06.0003
Received: 10 Aug., 2018    Accepted: 20 Sep., 2018    Published: 26 Oct., 2019

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Zhang J.Y., and Zhang D.W., 2018, The research progress of basal-like breast carcinoma, Cancer Genetics and Epigenetics, 6(3): 19-25 (doi: 10.5376/cge.2018.06.0003)

Basal-like breast carcinoma is a heterogeneous disease of high malignancy and poor prognosis, which is subordinate to breast carcinoma with high recurrence rate and distinctive route of metastasis. Comparing with osseous metastasis, basal-like breast carcinoma has more feasibility of metastasis to viscera. Chemotherapy is the only effectively therapy of basal-like breast carcinoma. Looking for the marker of basal-like breast carcinoma is supposed to be the tendency of the treatment of the disease.

Basal-like breast carcinoma; Triple negative breast carcinoma; Targeted therapy